Synarel (nafarelin acetate) — Point32Health
gender reassignment in adults (dysphoria / gender incongruence)
Initial criteria
- Documented diagnosis of dysphoria / gender incongruence
- Patient age ≥ 18 years
- Documentation patient will receive the requested agent concomitantly with cross sex hormones (testosterone or estrogen and spironolactone)